Calcitonin injection for shingles pain in older adults
Treatments studied
Part of Infections, Pain clinical trials.
This trial tests whether a medication called calcitonin (given as a shot under the skin) can help reduce pain in people with a recent shingles outbreak. It is for adults 50 and older who have moderate to severe pain from their rash.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years of age or older.
- You have a shingles rash that started within the last week.
- You are experiencing moderate to severe pain from the rash.
- You do not have bleeding or clotting problems.
- You do not have severe liver, heart, or kidney disease.
- You are not allergic to calcitonin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether calcitonin can prevent or lessen nerve pain after a spinal cord injury. It may help reduce how often neuropathic (nerve-type) pain happens and how severe it becomes.
This study tests whether electroacupuncture (a form of acupuncture with mild electrical stimulation) can reduce pain from shingles (herpes zoster), a viral infection that causes painful skin rashes. Researchers will also measure certain markers in your blood to understand how the treatment works.
This trial tests three injected treatments—tiny cell particles, platelet-rich plasma, and steroids—directly into the skin to reduce long-lasting nerve pain that follows shingles. If you've had persistent shingles pain for at least 3 months, this study may help ease your discomfort.
This trial tests an experimental vaccine designed to prevent shingles (a painful rash caused by the varicella-zoster virus). It will help see if the vaccine is safe and triggers a good immune response in adults 40 and older.
This trial tests a steroid medication given through an IV to reduce pain from shingles on the face. It aims to help people with severe pain that has lasted less than three months.
This trial tests a two-step procedure for treating nerve pain after shingles (called postherpetic neuralgia). First, a special type of radiofrequency treatment is applied to block the pain signals. Then, a long-lasting numbing medicine is injected under the skin to help keep the pain away. It is for people aged 40 to 85 who have not gotten enough relief from standard medicines.
Hear when a new Calcitonin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.